Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naimeng Yan"'
Autor:
Munawar Ayesha, Abbasi Majid, Dongting Zhao, Frederick T. Greenaway, Naimeng Yan, Qinlong Liu, Shuqing Liu, Ming-Zhong Sun
Publikováno v:
Journal of Advanced Research, Vol 36, Iss , Pp 147-161 (2022)
Introduction: Globally, hepatocellular carcinoma (HCC) is the sixth most common malignancy and it has the fourth highest mortality. MicroRNAs play a significant part in biological processes in cell formation and advancement by targeting genes in many
Externí odkaz:
https://doaj.org/article/14d0b4ac631d4c32b8b29dda856f9228
Autor:
Xiangming Fang, Haibo Mou, Xinxin Ying, Xuehua Hou, Luo Wang, Ying Wu, Naimeng Yan, Lijie Guo, Qin Liao
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Advanced or recurrent mucinous carcinoma of the ovary minimally responds to current cytotoxic treatments and has a poor prognosis. Despite multimodal treatment with chemotherapy and surgery, most patients ultimately progress and require palliative sy
Externí odkaz:
https://doaj.org/article/d76ad878cf7e423191845909626124f1
Autor:
Dongting Zhao, Shuqing Liu, Qinglong Liu, Abbasi Majid, Frederick T. Greenaway, Ming-Zhong Sun, Naimeng Yan, Munawar Ayesha
Publikováno v:
Journal of Advanced Research, Vol 36, Iss, Pp 147-161 (2022)
Journal of Advanced Research
Journal of Advanced Research
Graphical abstract Schematic illustration of the miR-4521-FAM129A axis in HCC malignancy. FAM129A negatively correlates with miR-4521, leading to suppressed migration and invasion by the TIMP-1/MMP9/MMP2 and EMT pathways. miR-4521-FAM129A axial regul
Autor:
NAIMENG YAN1, XUE FENG1, SIXIONG JIANG2, WEIBIN SUN2, MING-ZHONG SUN1, SHUQING LIU1 smzlsq@163.com
Publikováno v:
Oncology Letters. Jun2020, Vol. 19 Issue 6, p4115-4121. 7p.
Publikováno v:
Oncol Lett
Clear cell renal cell carcinoma (ccRCC) exhibits the highest mortality among all urological malignancies. The investigation of the potential disease progression markers can improve ccRCC diagnosis and treatment. Gene associated with retinoid-interfer
Autor:
Ming-Zhong Sun, Shanliang Zheng, Sixiong Jiang, Yuxiang Tian, Xue Feng, Weibin Sun, Shuqing Liu, Naimeng Yan, Chunmei Guo, Lihong Hao, Jinxia Wang
Publikováno v:
Cell Death Discovery
Cell Death Discovery, Vol 5, Iss 1, Pp 1-15 (2019)
Cell Death Discovery, Vol 5, Iss 1, Pp 1-15 (2019)
Clear cell renal cell carcinoma (ccRCC) is the most aggressive RCC subtype with high metastasis, chemotherapy and radiotherapy resistance, and poor prognosis. This study attempted to establish the deregulations of miR-4521 and FAM129A together with t